Biopharmaceutical Manufacturing
De Gruyter (Verlag)
978-3-11-061687-3 (ISBN)
lt;p>
Since joining BTEC in 2007, Gary Gilleskie has served in a number of positions, including director of operations from 2012-2017, and is currently BTEC's acting director. Dr. Gilleskie's work focuses on the area of downstream processing of biopharmaceuticals, including protein therapeutics and vaccines. While at BTEC, he has developed and taught numerous courses focused on downstream bioprocessing, for audiences ranging from NC State students to industry professionals to the U.S. Food and Drug Administration. He also started BTEC's bioprocess services program and has collaborated with a number of external organizations on developing processes and new bioprocessing technologies. Prior to joining BTEC, Dr. Gilleskie spent 15 years in both the chemical and biopharmaceutical industries. His biopharmaceutical experience comes from working for Bayer, in their plasma fractionation business unit, and Diosynth Biotechnology, a contract manufacturer of biopharmaceuticals. While at Diosynth, he managed downstream process development and cGMP manufacturing groups. He was involved in the development and manufacture of more than 10 different protein therapeutics produced in a variety of host systems. Dr. Gilleskie received his bachelor's degree in chemical engineering from NC State in 1986 and his doctorate in chemical engineering from the University of Minnesota in 1993.
Dr. Nathaniel Hentz is Assistant Director of the Analytical Lab at the Golden LEAF Biomanufacturing Training and Education Center (BTEC), where he provides analytical support for the various biomanufacturing processes taught at BTEC. He has nearly 12 years of experience developing high-throughput screening assays, automating and optimizing laboratory equipment and investigating new technologieswith Eli Lilly & Co. and Bristol-Myers Squibb. Dr. Hentz has also served as an independent consultant in the automated liquid handling quality control, microfluidic separations and ADME/tox fields. He received his Ph.D. in analytical chemistry from the University of Kentucky in 1996 and B.S. in chemistry from Eastern Michigan University in 1990.
Erscheinungsdatum | 26.08.2021 |
---|---|
Reihe/Serie | De Gruyter STEM |
Zusatzinfo | 30 b/w and 51 col. ill., 38 b/w tbl. |
Verlagsort | Berlin/Boston |
Sprache | englisch |
Maße | 170 x 240 mm |
Gewicht | 572 g |
Themenwelt | Technik ► Umwelttechnik / Biotechnologie |
Schlagworte | biopharmaceuticals • Biopharmazeutikum • Bioreaktor • GMP-Regel • Gute Herstellungspraxis • Manufacture • pharmaceutical production |
ISBN-10 | 3-11-061687-4 / 3110616874 |
ISBN-13 | 978-3-11-061687-3 / 9783110616873 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich